Interventions are needed to support patient–provider decision-making for DCIS: a scoping review Claire KimLaurel LiangAnna R. Gagliardi Review Open access 23 December 2017 Pages: 579 - 592
Breast cancer survivorship: state of the science Kathy PanArti HurriaRowan T. Chlebowski Review 13 January 2018 Pages: 593 - 600
Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma K. M. H. VangangeltG. W. van PeltW. E. Mesker Preclinical study Open access 22 December 2017 Pages: 601 - 612
Functional transcriptomic annotation and protein–protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer Miriam Nuncia-CantareroSandra Martinez-CanalesEva Maria Galan-Moya Preclinical study Open access 12 January 2018 Pages: 613 - 623
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer Melinda L. TelliJessica HellyerJames M. Ford Clinical trial 23 December 2017 Pages: 625 - 630
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06) Noam PondeIan BradburyEvandro de Azambuja Clinical trial 27 December 2017 Pages: 631 - 638
Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer Tufia C. HaddadAntonino D’AssoroJames N. Ingle Clinical trial Open access 30 December 2017 Pages: 639 - 647
Observation versus excision of lobular neoplasia on core needle biopsy of the breast Hank SchmidtBrittany ArditiShabnam Jaffer Clinical trial 03 January 2018 Pages: 649 - 654
Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer Annelie LiljegrenAnna von WachenfeldtBrita Arver Clinical trial Open access 09 January 2018 Pages: 655 - 666
Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study Yiqi PanSarah R. HeisigYvonne Nestoriuc Clinical trial Open access 12 January 2018 Pages: 667 - 677
Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival Ying ZhangYajie JiGuangyu Liu Clinical trial 13 January 2018 Pages: 679 - 686
Mammography use among women aged 18–39 years in the United States Jin QinMary C. WhiteIsaedmarie Febo-Vázquez Epidemiology 20 December 2017 Pages: 687 - 693
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients Al-Joharah AlhuqailAreej AlzahraniBedri Karakas Epidemiology 02 January 2018 Pages: 695 - 702
Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry Shengfeng WangFrank QianDezheng Huo Epidemiology 04 January 2018 Pages: 703 - 712
Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study Jung-Woo ChaePeh Siang ChuaAlexandre Chan Epidemiology 08 January 2018 Pages: 713 - 721
The impact of obesity on outcomes for patients undergoing mastectomy using the ACS-NSQIP data set Mary GarlandFang-Chi HsuMarissa Howard-McNatt Epidemiology 11 January 2018 Pages: 723 - 726
Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States Philip D. PoorvuInes Vaz-LuisMichael J. Hassett Epidemiology 13 January 2018 Pages: 727 - 737
Breast conserving surgery in combination with intraoperative radiotherapy after previous external beam therapy: an option to avoid mastectomy F. ThangarajahJ. HeilmannE. Sperk Epidemiology 15 January 2018 Pages: 739 - 744
BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia Milena JakimovskaIvana Maleva KostovskaDijana Plaseska-Karanfilska Epidemiology 15 January 2018 Pages: 745 - 753
Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors Tera L. FazzinoJennifer KlempChristie Befort Brief Report 22 December 2017 Pages: 755 - 761
Long-term use of basal insulin and the risk of breast cancer Karel KostevMatthias Kalder Letter to the Editor 26 December 2017 Pages: 763 - 764
20-year risk of breast cancer recurrence Karel KostevMatthias Kalder Letter to the Editor 03 January 2018 Pages: 765 - 766
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? Sara BravacciniAndrea RoccaGiuseppe Bronte Letter to the Editor 06 January 2018 Pages: 767 - 768
Comment on a meta-analysis evaluating the cardiac toxicity of lapatinib in patients with breast cancer and other HER2-positive cancers Qixing TanChangyuan Wei Letter to the Editor 12 January 2018 Pages: 769 - 770
Consideration of population and cultural factors in American Indian/Alaskan Native (AIAN) research Susanna N. Basappa Letter to the Editor 13 January 2018 Pages: 771 - 772
How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer? Matteo LambertiniCaterina Fontanella Letter to the Editor 15 January 2018 Pages: 773 - 774
